The role of chemotherapy in the treatment of bone and soft tissue sarcomas

被引：2
作者：
Longhi, A [1 ]
Setola, E [1 ]
Versari, M [1 ]
Bacci, G [1 ]
机构：
[1] Ist Ortoped Rizzoli, Dept Musculoskeletal Oncol, I-40136 Bologna, Italy
来源：
CURRENT ORTHOPAEDICS | 2005年 / 19卷 / 02期
关键词：
sarcomas; bone; soft tissue; chemotherapy;
D O I：
10.1016/j.cuor.2005.02.009
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
White surgery remains the cornerstone of treatment of bone and soft tissue sarcomas, chemotherapy has improved the 5-year overall survival in osteosarcoma and Ewing's sarcoma from 10% to 70% in localized disease. Patients with metastases at presentation treated with surgery combined with chemotherapy have a 3-year survival of 30-50%, but cure is stilt rare. The role of adjuvant chemotherapy in soft tissue sarcoma has yet to be determined, but it is likely that some patients will benefit. As some bone sarcomas do not respond to chemotherapy, surgery remains the only effective treatment, and there are no effective drugs to treat relapsing patients. Radiotherapy has both a curative role in combination with chemotherapy in soft tissue and Ewing's sarcoma and a palliative rote in the other sarcomas. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：119 / 126
页数：8
相关论文
共 50 条
  • [41] A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas
    Khoury, Rita
    Assi, Tarek
    Ibrahim, Rebecca
    Ibrahim, Tony
    Verret, Benjamin
    Henon, Clemence
    Bahleda, Ratislav
    Le Cesne, Axel
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (02) : 176 - 190
  • [42] A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas
    Rita Khoury
    Tarek Assi
    Rebecca Ibrahim
    Tony Ibrahim
    Benjamin Verret
    Clemence Henon
    Ratislav Bahleda
    Axel Le Cesne
    Current Treatment Options in Oncology, 2024, 25 : 176 - 190
  • [43] Translocation in bone and soft tissue sarcomas: a comprehensive epidemiological investigation
    Kawaguchi, K.
    Endo, M.
    Shimada, E.
    Kohashi, K.
    Hirose, T.
    Nabeshima, A.
    Fujiwara, T.
    Kawai, A.
    Oda, Y.
    Nakashima, Y.
    ESMO OPEN, 2024, 9 (10)
  • [44] Systemic therapy of soft tissue sarcomas
    Pink, D.
    Bertz-Lepel, J.
    Reichardt, P.
    PATHOLOGE, 2011, 32 (01): : 65 - 71
  • [45] Plastic surgery possibilities in the treatment of soft tissue sarcomas
    Lehnhardt, M.
    Harati, K.
    Goertz, O.
    Ring, A.
    Daigeler, A.
    ONKOLOGE, 2014, 20 (11): : 1103 - +
  • [46] Systemic Treatment of Soft Tissue Sarcomas in the Geriatric Population
    Mia C. Weiss
    Current Treatment Options in Oncology, 2022, 23 : 855 - 863
  • [47] METASTASECTOMY FOLLOWING CHEMOTHERAPY IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMAS
    WEH, HJ
    ZORNIG, C
    HOFFKNECHT, MH
    SCHWARZ, R
    HOSSFELD, DK
    ONKOLOGIE, 1992, 15 (06): : 470 - 474
  • [48] Secondary tumors in bone sarcomas after treatment with chemotherapy
    Ferrari, C
    Bohling, T
    Benassi, MS
    Ferraro, A
    Gamberi, G
    Bacci, G
    del Prever, AB
    Sangiorgi, L
    Ragazzini, P
    Sollazzo, MR
    Balladelli, A
    Picci, P
    CANCER DETECTION AND PREVENTION, 1999, 23 (05): : 368 - 374
  • [49] Early Outcomes of Soft Tissue Sarcomas Presenting With Metastases and Treated With Chemotherapy
    King, Joseph J.
    Fayssoux, Reginald S.
    Lackman, Richard D.
    Ogilvie, Christian M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 308 - 313
  • [50] Advances in systemic treatment of advanced soft tissue sarcomas
    Dudzisz-Sledz, Monika
    Rogala, Pawel
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (06): : 377 - 391
12345